title: Somatostatin analogs in the medical management of occult bleeding of the lower digestive tract.
abstract: The management of occult bleeding from the lower digestive tract can be very challenging. In cases of identified angiodysplasia, the first line management options can be limited by a number of clinical or anatomical factors and an alternative approach might be required, including the use of medications. Somatostatin analogs have been considered as an effective and well-tolerated alternative management option in a number of cases where the endoscopic therapeutic approach is not practical or is unsuccessful, in patients with coagulopathies or who need concomitant anticoagulation or antiplatelet treatment. Despite the lack of double-blinded randomized placebo-control trials and despite the limitations of the available evidence in the literature, including small sample size, variable dosing, and administration routes, there is a consistent agreement in the literature that somatostatin analogs are a safe, well-tolerated, and effective therapeutic option for managing refractory or occult bleeding from the lower digestive tract, with particular reference to patients with angiodysplasia, where endoscopic or surgical management is either not feasible or unsuccessful and other pharmacological options are not preferred.
authors.affiliation: Department of Medicine, St. Michael's Hospital, Dun Laoghaire, County Dublin, Ireland.
authors.forename: Julie
authors.initials: J
authors.lastname: Martin-Grace
authors.affiliation: Department of General Internal Medicine, St. Columcille's Hospital, Loughlinstown, County Dublin, Ireland.
authors.forename: Gianluca
authors.initials: G
authors.lastname: Tamagno
references.citation: Br J Haematol. 2000 Mar;108(3):524-7
references.pmid: 10759709
references.citation: Gastroenterology. 2001 Nov;121(5):1073-9
references.pmid: 11677198
references.citation: Rev Esp Enferm Dig. 2012 Feb;104(2):69-71
references.pmid: 22372800
references.citation: Digestion. 1999;60 Suppl 3:1-16
references.pmid: 10567784
references.citation: Am J Gastroenterol. 1999 Apr;94(4):1077-82
references.pmid: 10201486
references.citation: Dig Liver Dis. 2004 Dec;36(12):843-6
references.pmid: 15646433
references.citation: Am J Gastroenterol. 1993 Sep;88(9):1424-7
references.pmid: 8362842
references.citation: Dig Dis Sci. 2010 Aug;55(8):2129-34
references.pmid: 20393879
references.citation: Scand J Gastroenterol. 2003 Jul;38(7):801-3
references.pmid: 12889571
references.citation: Aliment Pharmacol Ther. 1999 Nov;13(11):1429-36
references.pmid: 10571598
references.citation: J Surg Res. 1993 Oct;55(4):446-50
references.pmid: 7692142
references.citation: Gastrointest Endosc. 2004 Jan;59(1):81-8
references.pmid: 14722558
references.citation: J Clin Gastroenterol. 1992 Sep;15(2):99-103
references.pmid: 1328358
references.citation: Am J Gastroenterol. 2007 Feb;102(2):254-60
references.pmid: 17311647
references.citation: Dig Liver Dis. 2014 Aug;46(8):688-94
references.pmid: 24893688
references.citation: Aliment Pharmacol Ther. 2014 Jan;39(1):15-34
references.pmid: 24138285
references.citation: Aliment Pharmacol Ther. 2007 Sep 15;26(6):935-42
references.pmid: 17767478
references.citation: Aliment Pharmacol Ther. 2012 Sep;36(6):587-93
references.pmid: 22831465
references.citation: Dig Liver Dis. 2001 May;33(4):330-4
references.pmid: 11432511
references.citation: Am J Gastroenterol. 1993 Jun;88(6):807-18
references.pmid: 8389094
references.citation: Gastroenterology. 2000 Jan;118(1):197-201
references.pmid: 10611169
references.citation: Gastroenterology. 2011 Nov;141(5):1629-37.e1-4
references.pmid: 21784047
references.citation: Scand J Gastroenterol Suppl. 1998;228:115-21
references.pmid: 9867121
references.citation: Digestion. 1993;54 Suppl 1:59-67
references.pmid: 8359570